Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “BCR-ABL Positive Chronic Myelogenous Leukemia”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT01053494
What this trial is testing

Massage Therapy Given by Caregiver in Treating Quality of Life of Young Patients Undergoing Treatment for Cancer

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAcute Undifferentiated LeukemiaAngioimmunoblastic T-cell Lymphoma+84 more
Wake Forest University Health Sciences 80
Not applicableStudy completedNCT00896129
What this trial is testing

Mid-to Long-Term Outcomes in Chronic Myeloid Leukemia (CML) Patients With Complete Cytogenetic Response After Imatinib as First Line Therapy

Who this might be right for
Chronic Myeloid Leukemia
Gruppo Italiano Malattie EMatologiche dell'Adulto 448
Testing effectiveness (Phase 2)Ended earlyNCT00415857
What this trial is testing

Proteinase 3 PR1 Peptide Mixed With Montanide ISA-51 VG Adjuvant and Administered With GM-CSF and PEG-INTRON(R)

Who this might be right for
Leukemia
M.D. Anderson Cancer Center 5
Testing effectiveness (Phase 2)Study completedNCT00002502
What this trial is testing

Combination Chemotherapy and Bone Marrow Transplantation in Treating Patients With Leukemia or Myelodysplastic Syndrome

Who this might be right for
LeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+1 more
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Study completedNCT01916785
What this trial is testing

OPTIM DASATINIB (Optimized Tyrosine Kinase Inhibitors Monotherapy)

Who this might be right for
Chronic Myelogenous Leukemia, BCR/ABL Positive
Versailles Hospital 289
Early research (Phase 1)Study completedNCT01068301
What this trial is testing

A Pediatric Study of a Plerixafor Containing Regimen In Second Allogeneic Stem Cell Transplantation

Who this might be right for
Acute Lymphoblastic LeukemiaAcute Myeloid LeukemiaChronic Myeloid Leukemia+2 more
St. Jude Children's Research Hospital 12
Testing effectiveness (Phase 2)Ended earlyNCT00540995
What this trial is testing

Busulfan, Etoposide, and Intensity-Modulated Radiation Therapy Followed By Donor Stem Cell Transplant in Treating Patients With Advanced Myeloid Cancer

Who this might be right for
Adult Acute Myeloid Leukemia in RemissionAdult Acute Myeloid Leukemia With 11q23 (MLL) AbnormalitiesAdult Acute Myeloid Leukemia With Del(5q)+12 more
City of Hope Medical Center 25
Early research (Phase 1)Study completedNCT00003395
What this trial is testing

Arsenic Trioxide in Treating Patients With Advanced Hematologic Cancer

Who this might be right for
LeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07804901
What this trial is testing

Asciminib Frontline Risk Adapted

Who this might be right for
Chronic Myeloid Leukemia (CML)
Prof. Dr. med. Andreas Hochhaus 200
Not applicableStudy completedNCT02389972
What this trial is testing

Effectiveness of Dasatinib in Adult Patients With Chronic Myeloid Leukemia in China: A Multicenter, Registry Study

Who this might be right for
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Bristol-Myers Squibb 128
Not applicableEnded earlyNCT01490775
What this trial is testing

Pilot Study to Assess Telemonitoring of Gleevec (Imatinib Mesylate) or Tasigna (Niltinib) Therapy

Who this might be right for
Chronic Phase CML
Rex Cancer Center, Raleigh, NC 27
Testing effectiveness (Phase 2)Study completedNCT01858740
What this trial is testing

Selective Depletion of CD45RA+ T Cells From Allogeneic Peripheral Blood Stem Cell Grafts in Preventing GVHD in Children

Who this might be right for
Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 PositiveAcute Biphenotypic LeukemiaAcute Leukemia of Ambiguous Lineage+15 more
Fred Hutchinson Cancer Center 20
Not applicableWithdrawnNCT02663648
What this trial is testing

Cell Cycle Regulatory Gene Study in Patients With Myeloproliferative Disorders

Who this might be right for
Myeloproliferative DisordersPolycythemia VeraEssential Thrombocythemia+2 more
Shandong University
Testing effectiveness (Phase 2)WithdrawnNCT00081055
What this trial is testing

OTI-010 for Graft-Versus-Host Disease Prophylaxis in Treating Patients Who Are Undergoing Donor Peripheral Stem Cell Transplantation for Hematologic Malignancies

Who this might be right for
Graft Versus Host DiseaseLeukemiaMyelodysplastic Syndromes
Mesoblast International Sàrl
Testing effectiveness (Phase 2)Study completedNCT00145626
What this trial is testing

HLA-Nonidentical Stem Cell and Natural Killer Cell Transplantation for Children Less the Two Years of Age With Hematologic Malignancies

Who this might be right for
Acute Myeloid LeukemiaAcute Lymphocytic LeukemiaMyelodysplasia+2 more
St. Jude Children's Research Hospital 40
Testing effectiveness (Phase 2)Study completedNCT00516152
What this trial is testing

Phase II Study Evaluating Busulfan and Fludarabine as Preparative Therapy in Adults With Hematopoietic Disorders Undergoing MUD SCT

Who this might be right for
Chronic Myeloid LeukemiaAcute Myelogenous LeukemiaMyelodysplasia+6 more
University of California, San Francisco 36
Testing effectiveness (Phase 2)Study completedNCT00219726
What this trial is testing

Safety and Efficacy of Imatinib in Chronic Myelogenous Patients in Relapse After Stem Cell Transplantation

Who this might be right for
Chronic Myeloid Leukemia
Poitiers University Hospital 30
Testing effectiveness (Phase 2)Study completedNCT01720264
What this trial is testing

Multicenter Phase II of CD26 Using Sitagliptin for Engraftment After UBC Transplant

Who this might be right for
Acute Myeloid LeukemiaAcute Lymphoid LeukemiaHematopoetic Myelodysplasia+2 more
Sherif S. Farag 15
Testing effectiveness (Phase 2)Ended earlyNCT00052598
What this trial is testing

Therapeutic Allogeneic Lymphocytes and Aldesleukin in Treating Patients With High-Risk or Recurrent Myeloid Leukemia After Undergoing Donor Stem Cell Transplant

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAcute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic SyndromeAdult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities+12 more
Fred Hutchinson Cancer Center 7
Testing effectiveness (Phase 2)WithdrawnNCT03602898
What this trial is testing

Comparing ATG or Post-Transplant Cyclophosphamide to Calcineurin Inhibitor-Methotrexate as GVHD Prophylaxis After Myeloablative Unrelated Donor Peripheral Blood Stem Cell Transplantation

Who this might be right for
Acute Lymphoblastic Leukemia in RemissionAcute Myeloid Leukemia Arising From Previous Myelodysplastic SyndromeChronic Myelomonocytic Leukemia+10 more
Fred Hutchinson Cancer Center
Next Page